Analysts expect NRX Pharmaceuticals, Inc. to report revenue of 1.28 M for Q3 26, against a range of 1.16 M to 1.40 M. The most recent reported quarter, Q2 26, came in at 1.10 M, a 22.2% miss against the 1.41 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 2.27 M | 0.00 | 242,000.00 | 991,500.00 | 1.07 M | 1.10 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 4.10 M | 6.79 M | 7.59 M | 21.97 M | 1.48 M | 1.40 M | 2.86 M | 15.00 M | 38.12 M | 26.09 M | 20.09 M | 116.72 M | 147.75 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 3.38 M | 6.19 M | 6.87 M | 18.00 M | 1.35 M | 1.16 M | 2.45 M | 14.11 M | 31.59 M | 21.73 M | 18.17 M | 103.28 M | 131.14 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 3.74 M | 6.49 M | 7.23 M | 19.98 M | 1.41 M | 1.28 M | 2.66 M | 14.55 M | 34.85 M | 23.91 M | 19.13 M | 110.00 M | 139.45 M |
Analysts expect NRX Pharmaceuticals, Inc. to report earnings per share of -0.20 for Q3 26, against a range of -0.21 to -0.19. The most recent reported quarter, Q2 26, came in at -0.44, a 340.0% miss against the -0.10 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.15 | -0.72 | -0.34 | -0.98 | -0.27 | 0.01 | -0.04 | -0.44 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.53 | -0.34 | -0.28 | -0.14 | -0.02 | 0.01 | 0.24 | -0.09 | -0.19 | -0.22 | -0.15 | -0.11 | 0.05 | -0.05 | -0.04 | -0.10 | ||||||||||
| Low Estimate | -0.63 | -0.38 | -0.30 | -0.16 | -0.02 | 0.01 | 0.20 | -0.11 | -0.21 | -0.26 | -0.17 | -0.13 | 0.05 | -0.07 | -0.04 | -0.10 | ||||||||||
| Consensus Estimate | -0.58 | -0.36 | -0.29 | -0.15 | -0.02 | 0.01 | 0.22 | -0.10 | -0.20 | -0.24 | -0.16 | -0.12 | 0.05 | -0.06 | -0.04 | -0.10 |
Pull Wall Street consensus for NRX Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NRXP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NRXP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NRXP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();